FolioLanternBeta
PFEPfizer

James Quincey

Director at Pfizer, as of Sep 29, 2026Sold $145M of stock in the past 12 months: 75% under a disclosed plan and 25% with no plan disclosed.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
2
companies filed for

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planNo plan disclosedOne dollar scale for every month; the tallest bar is labeled
OctNovDecJanFeb 2026: $26.0M under a disclosed planFebMar 2026: $19.8M no plan disclosedMarAprMay 2026: $15.8M no plan disclosedMayJun 2026: $35.6M under a disclosed planJunJul 2026: $47.5M under a disclosed plan$47.5MJulAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Pfizer (PFE)DirectorMar 2, 2020Sep 29, 2026
Coca-Cola Company (KO)Chairman, DirectorJan 10, 2013Jul 30, 2026

Also a director at

Coca-Cola Company (KO)

Recent filings

The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.